TILT Holdings Inc (TLLTF)
0.0201
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
TILT Holdings Enterprise Value: 65.78M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 65.78M |
| June 21, 2024 | 66.25M |
| June 20, 2024 | 66.02M |
| June 18, 2024 | 67.33M |
| June 17, 2024 | 67.33M |
| June 14, 2024 | 69.66M |
| June 13, 2024 | 69.46M |
| June 12, 2024 | 71.01M |
| June 11, 2024 | 70.47M |
| June 10, 2024 | 69.66M |
| June 07, 2024 | 70.05M |
| June 06, 2024 | 70.92M |
| June 05, 2024 | 70.82M |
| June 04, 2024 | 72.18M |
| June 03, 2024 | 71.21M |
| May 31, 2024 | 71.79M |
| May 30, 2024 | 72.10M |
| May 29, 2024 | 70.96M |
| May 28, 2024 | 71.50M |
| May 24, 2024 | 72.18M |
| May 23, 2024 | 69.66M |
| May 22, 2024 | 70.12M |
| May 21, 2024 | 70.05M |
| May 20, 2024 | 71.63M |
| May 17, 2024 | 70.92M |
| Date | Value |
|---|---|
| May 16, 2024 | 70.82M |
| May 15, 2024 | 69.46M |
| May 14, 2024 | 71.09M |
| May 13, 2024 | 70.80M |
| May 10, 2024 | 71.40M |
| May 09, 2024 | 71.32M |
| May 08, 2024 | 70.59M |
| May 07, 2024 | 71.01M |
| May 06, 2024 | 70.36M |
| May 03, 2024 | 70.32M |
| May 02, 2024 | 69.93M |
| May 01, 2024 | 69.46M |
| April 30, 2024 | 71.79M |
| April 29, 2024 | 67.88M |
| April 26, 2024 | 68.88M |
| April 25, 2024 | 68.30M |
| April 24, 2024 | 69.91M |
| April 23, 2024 | 68.88M |
| April 22, 2024 | 68.69M |
| April 19, 2024 | 69.19M |
| April 18, 2024 | 70.59M |
| April 17, 2024 | 69.93M |
| April 16, 2024 | 70.00M |
| April 15, 2024 | 70.01M |
| April 12, 2024 | 69.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
55.01M
Minimum
Jun 14 2023
312.94M
Maximum
Feb 10 2021
146.03M
Average
149.75M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.982M |
| Palatin Technologies Inc | 19.35M |
| iBio Inc | 26.41M |
| Theriva Biologics Inc | -11.08M |
| Oragenics Inc | 5.495M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.651M |
| Revenue (Quarterly) | 37.50M |
| Total Expenses (Quarterly) | 42.88M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 17.91% |
| Profit Margin (Quarterly) | -25.73% |
| Earnings Yield | -880.8% |
| Normalized Earnings Yield | -673.53 |